Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study	CLINICAL GENITOURINARY CANCER	2022
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications	JOURNAL OF THE NATIONAL CANCER INSTITUTE	2022
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature	CANCER TREATMENT REVIEWS	2022
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy	JOURNAL OF CHEMOTHERAPY	2022
Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report	ANTI-CANCER DRUGS	2022
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)	EXPERT REVIEW OF ANTICANCER THERAPY	2022
Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors	JOURNAL OF BONE ONCOLOGY	2022
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel	CANCERS	2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study	CANCERS	2022
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO	CLINICAL COLORECTAL CANCER	2022
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline	ANNALS OF ONCOLOGY	2022
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation	BIOMEDICINES	2022
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study	BREAST CANCER RESEARCH	2022
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index	EUROPEAN JOURNAL OF CANCER	2021
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation	CANCER IMMUNOLOGY, IMMUNOTHERAPY	2021
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice	FRONTIERS IN ONCOLOGY	2021
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO	BRITISH JOURNAL OF CANCER	2021
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort	JOURNAL OF TRANSLATIONAL MEDICINE	2021
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting	THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY	2021
A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients	TRANSLATIONAL LUNG CANCER RESEARCH	2021